-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Elebsiran
| Category | Hepatitis B Virus (HBV) |
| CAS | 2648009-64-5 |
| Description | Elebsiran, an antiviral agent against hepatitis B and D virus infections, is a small interfering RNA (siRNA) therapeutic designed to target and silence specific mRNA sequences responsible for the production of pathogenic proteins. Its mechanism of action involves the degradation of targeted mRNA, thereby preventing the synthesis of proteins that contribute to disease progression. |
Product Information
| Synonyms | VIR-2218 |
| Molecular Weight | 487.5 |
| Molecular Formula | C18H16F3N5O4S2 |
| Canonical SMILES | COC(=O)C1=C2C[C@@H](CN2C(=N[C@H]1C3=C(C(=C(C=C3)F)F)F)C4=NC=CS4)NS(=O)(=O)N |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
